应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02216 堃博医疗-B
未开盘 04-25 16:09:09
0.510
-0.030
-5.56%
最高
0.540
最低
0.510
成交量
1.35万
今开
0.540
昨收
0.540
日振幅
5.56%
总市值
2.69亿
流通市值
2.69亿
总股本
5.27亿
成交额
6,900
换手率
0.00%
流通股本
5.27亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
堃博医疗-B盘中异动 股价大跌5.56%
自选股智能写手 · 04-25 14:58
堃博医疗-B盘中异动 股价大跌5.56%
(坤)博医疗-B(02216)股价下跌9.615%,现价港币$0.47
阿斯达克财经 · 04-24 10:25
(坤)博医疗-B(02216)股价下跌9.615%,现价港币$0.47
堃博医疗-B盘中异动 下午盘股价大跌5.56%报0.510港元
自选股智能写手 · 04-23 13:56
堃博医疗-B盘中异动 下午盘股价大跌5.56%报0.510港元
堃博医疗-B(02216.HK)委任董事长
阿斯达克财经 · 04-22
堃博医疗-B(02216.HK)委任董事长
堃博医疗-B公布委任徐宏为董事长
新浪港股 · 04-22
堃博医疗-B公布委任徐宏为董事长
堃博医疗-B(02216)委任徐宏为董事长
智通财经 · 04-19
堃博医疗-B(02216)委任徐宏为董事长
堃博医疗-B盘中异动 临近收盘股价大跌5.26%报0.540港元
自选股智能写手 · 04-17
堃博医疗-B盘中异动 临近收盘股价大跌5.26%报0.540港元
堃博医疗-B股价飙升13.21% 市值涨4178.59万港元
自选股智能写手 · 04-12
堃博医疗-B股价飙升13.21% 市值涨4178.59万港元
(坤)博医疗-B(02216)股价显著上升13.208%,现价港币$0.6
阿斯达克财经 · 04-12
(坤)博医疗-B(02216)股价显著上升13.208%,现价港币$0.6
堃博医疗-B盘中异动 股价大跌9.61%
自选股智能写手 · 04-11
堃博医疗-B盘中异动 股价大跌9.61%
堃博医疗-B盘中异动 早盘股价大跌9.09%报0.500港元
自选股智能写手 · 04-09
堃博医疗-B盘中异动 早盘股价大跌9.09%报0.500港元
堃博医疗-B股价重挫10.53% 市值跌2831.2万港元
自选股智能写手 · 04-02
堃博医疗-B股价重挫10.53% 市值跌2831.2万港元
(坤)博医疗-B(02216)股价显著下跌10.526%,现价港币$0.51
阿斯达克财经 · 04-02
(坤)博医疗-B(02216)股价显著下跌10.526%,现价港币$0.51
堃博医疗-B(02216)年报点评:内生收入快速增长,期待持续改善
华泰证券 · 04-01
堃博医疗-B(02216)年报点评:内生收入快速增长,期待持续改善
堃博医疗-B(02216)发2023年度业绩,股东应占亏损2809.1万美元,同比扩大0.2%
智通财经 · 03-28
堃博医疗-B(02216)发2023年度业绩,股东应占亏损2809.1万美元,同比扩大0.2%
堃博医疗(02216.HK)公布2023年年度业绩
美通社 · 03-28
堃博医疗(02216.HK)公布2023年年度业绩
堃博医疗-B盘中异动 急速下挫6.35%报0.590港元
自选股智能写手 · 03-20
堃博医疗-B盘中异动 急速下挫6.35%报0.590港元
堃博医疗-B(02216.HK)即将审批2023年全年业绩
和讯网 · 03-18
堃博医疗-B(02216.HK)即将审批2023年全年业绩
堃博医疗-B(02216.HK)将于3月28日举行董事会会议以审批全年业绩
格隆汇资讯 · 03-18
堃博医疗-B(02216.HK)将于3月28日举行董事会会议以审批全年业绩
堃博医疗-B盘中异动 股价大跌5.97%
自选股智能写手 · 03-18
堃博医疗-B盘中异动 股价大跌5.97%
加载更多
公司概况
公司名称:
堃博医疗-B
所属市场:
SEHK
上市日期:
--
主营业务:
堃博医疗控股有限公司是一家提供创新型肺部疾病解决方案的中国投资控股公司。该公司的业务包括提供诊断解决方案、肺癌治疗解决方案、慢性阻塞性肺病解决方案和导航平台。诊断解决方案的产品包括FleXNeedle,ATV鞘管和ATV球囊等。肺癌治疗解决方案产品包括针对肺癌的InterVapor和H-Marker等。慢性阻塞性肺病解决方案产品包括针对慢性阻塞性肺病的InterVapor和靶向肺去神经消融系统。导航平台产品包括Lungpoint,Lungpro,和新一代导航系统等。
发行价格:
--
{"stockData":{"symbol":"02216","market":"HK","secType":"STK","nameCN":"堃博医疗-B","latestPrice":0.51,"timestamp":1714032549014,"preClose":0.54,"halted":0,"volume":13500,"delay":0,"floatShares":527198076,"shares":527198076,"eps":-0.45011586,"marketStatus":"未开盘","marketStatusCode":0,"change":-0.03,"latestTime":"04-25 16:09:09","open":0.54,"high":0.54,"low":0.51,"amount":6900,"amplitude":0.055556,"askPrice":0.53,"askSize":2000,"bidPrice":0.5,"bidSize":210000,"shortable":0,"etf":0,"ttmEps":-0.450115863969437,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1714095000000},"adr":0,"listingDate":1632412800000,"adjPreClose":0.54,"openAndCloseTimeList":[[1714008600000,1714017600000],[1714021200000,1714032000000]],"volumeRatio":0.248619,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02216","defaultTab":"news","newsList":[{"id":"2430538426","title":"堃博医疗-B盘中异动 股价大跌5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430538426","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430538426?lang=zh_cn&edition=full","pubTime":"2024-04-25 14:58","pubTimestamp":1714028309,"startTime":"0","endTime":"0","summary":"2024年04月25日下午盘14时58分,堃博医疗-B股票出现异动,股价快速下跌5.56%。截至发稿,该股报0.510港元/股,成交量1000股,换手率0.00%,振幅5.56%。堃博医疗-B股票所在的医疗设备及用品行业中,整体涨幅为0.06%。堃博医疗-B公司简介:堃博医疗控股有限公司是一家提供创新型肺部疾病解决方案的中国投资控股公司。肺癌治疗解决方案产品包括针对肺癌的InterVapor和H-Marker等。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240425145829861e8db2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240425145829861e8db2&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429174893","title":"(坤)博医疗-B(02216)股价下跌9.615%,现价港币$0.47","url":"https://stock-news.laohu8.com/highlight/detail?id=2429174893","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2429174893?lang=zh_cn&edition=full","pubTime":"2024-04-24 10:25","pubTimestamp":1713925500,"startTime":"0","endTime":"0","summary":"[下跌股](坤)博医疗-B(02216) 股价在上午10:25比前收市价下跌9.615%,现股价为港币$0.47。至目前为止,今日最高价为$0.47,而最低价为$0.47。总成交量为500股,总成交金额为港币$235。","market":"sh","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180112133700459_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180112133700459_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2404241242/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2429942153","title":"堃博医疗-B盘中异动 下午盘股价大跌5.56%报0.510港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429942153","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429942153?lang=zh_cn&edition=full","pubTime":"2024-04-23 13:56","pubTimestamp":1713851809,"startTime":"0","endTime":"0","summary":"2024年04月23日下午盘13时56分,堃博医疗-B股票出现波动,股价快速下挫5.56%。截至发稿,该股报0.510港元/股,成交量20.5万股,换手率0.04%,振幅0.00%。资金方面,该股资金流入0港元,流出2550港元。堃博医疗-B股票所在的医疗设备及用品行业中,整体涨幅为0.17%。肺癌治疗解决方案产品包括针对肺癌的InterVapor和H-Marker等。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404231356497a54c0c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404231356497a54c0c9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429965094","title":"堃博医疗-B(02216.HK)委任董事长","url":"https://stock-news.laohu8.com/highlight/detail?id=2429965094","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2429965094?lang=zh_cn&edition=full","pubTime":"2024-04-22 09:15","pubTimestamp":1713748500,"startTime":"0","endTime":"0","summary":"堃博医疗-B(02216.HK) 公布,赵亦伟已辞任非执行董事 、 董事长、薪酬委员会成员、提名委员会主席 及授权代表;执行董事徐宏已获委任为董事长,均自4月19日起生效。徐宏负责参与制定公司的企业及业务策略。(ha/w)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20220216155332872_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20220216155332872_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1343791/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0},{"id":"2429683409","title":"堃博医疗-B公布委任徐宏为董事长","url":"https://stock-news.laohu8.com/highlight/detail?id=2429683409","media":"新浪港股","top":-1,"share":"https://www.laohu8.com/m/news/2429683409?lang=zh_cn&edition=full","pubTime":"2024-04-22 08:19","pubTimestamp":1713745140,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n 堃博医疗-B(02216)公布,自2024年4月19日起,赵亦伟已辞任非执行董事、董事长、薪酬委员会成员、提名委员会主席及授权代表;湛国威已辞任非执行董事;徐宏已获委任为董事长、提名委员会主席及授权代表;邝艳红已获委任为非执行董事及薪酬委员会成员;及David Scott Lim已获委任为独立非执行董事以及审核委员会及提名委员会各自的成员。\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:卢昱君","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-04-22/doc-inassfia2237205.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-04-22/doc-inassfia2237205.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2428668229","title":"堃博医疗-B(02216)委任徐宏为董事长","url":"https://stock-news.laohu8.com/highlight/detail?id=2428668229","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2428668229?lang=zh_cn&edition=full","pubTime":"2024-04-19 22:55","pubTimestamp":1713538556,"startTime":"0","endTime":"0","summary":"智通财经APP讯,堃博医疗-B(02216)公布,自2024年4月19日起,赵亦伟已辞任非执行董事、董事长、薪酬委员会成员、提名委员会主席及授权代表;湛国威已辞任非执行董事;徐宏已获委任为董事长、提名委员会主席及授权代表;邝艳红已获委任为非执行董事及薪酬委员会成员;及David Scott Lim已获委任为独立非执行董事以及审核委员会及提名委员会各自的成员。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1105941.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2428136054","title":"堃博医疗-B盘中异动 临近收盘股价大跌5.26%报0.540港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428136054","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428136054?lang=zh_cn&edition=full","pubTime":"2024-04-17 15:38","pubTimestamp":1713339488,"startTime":"0","endTime":"0","summary":"2024年04月17日临近收盘15时38分,堃博医疗-B股票出现异动,股价大幅下挫5.26%。截至发稿,该股报0.540港元/股,成交量3.45万股,换手率0.01%,振幅7.02%。资金方面,该股资金流入1.87万港元,流出255港元。堃博医疗-B股票所在的医疗设备及用品行业中,整体涨幅为0.04%。堃博医疗-B公司简介:堃博医疗控股有限公司是一家提供创新型肺部疾病解决方案的中国投资控股公司。肺癌治疗解决方案产品包括针对肺癌的InterVapor和H-Marker等。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404171538087a536225&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404171538087a536225&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426277805","title":"堃博医疗-B股价飙升13.21% 市值涨4178.59万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426277805","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426277805?lang=zh_cn&edition=full","pubTime":"2024-04-12 15:55","pubTimestamp":1712908553,"startTime":"0","endTime":"0","summary":"2024年04月12日临近收盘15时55分,堃博医疗-B股票出现波动,股价急速上涨13.21%。资金方面,该股资金流入300港元,流出0港元。堃博医疗-B股票所在的医疗设备及用品行业中,整体跌幅为0.07%。其相关个股中,堃博医疗-B、巨星医疗控股、业聚医疗涨幅较大,振幅较大的相关个股有智云健康、健世科技-B、巨星医疗控股,振幅分别为19.49%、11.61%、10.42%。肺癌治疗解决方案产品包括针对肺癌的InterVapor和H-Marker等。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041215555387e7fe6c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041215555387e7fe6c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426775982","title":"(坤)博医疗-B(02216)股价显著上升13.208%,现价港币$0.6","url":"https://stock-news.laohu8.com/highlight/detail?id=2426775982","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2426775982?lang=zh_cn&edition=full","pubTime":"2024-04-12 15:55","pubTimestamp":1712908500,"startTime":"0","endTime":"0","summary":"[上升股](坤)博医疗-B(02216) 股价在下午03:55比前收市价显著上升13.208%,现股价为港币$0.6。至目前为止,今日最高价为$0.6,而最低价为$0.6。总成交量为500股,总成交金额为港币$300。","market":"fut","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180205152547499_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180205152547499_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2404123031/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2426471847","title":"堃博医疗-B盘中异动 股价大跌9.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426471847","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426471847?lang=zh_cn&edition=full","pubTime":"2024-04-11 09:30","pubTimestamp":1712799014,"startTime":"0","endTime":"0","summary":"2024年04月11日早盘09时30分,堃博医疗-B股票出现波动,股价快速跳水9.61%。堃博医疗-B股票所在的医疗设备及用品行业中,整体涨幅为0.01%。其相关个股中,健世科技-B、微创机器人-B、康基医疗涨幅较大,振幅较大的相关个股有微创医疗、健世科技-B、微创机器人-B,振幅分别为2.98%、2.67%、1.39%。堃博医疗-B公司简介:堃博医疗控股有限公司是一家提供创新型肺部疾病解决方案的中国投资控股公司。肺癌治疗解决方案产品包括针对肺癌的InterVapor和H-Marker等。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404110930147a5202da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404110930147a5202da&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426901449","title":"堃博医疗-B盘中异动 早盘股价大跌9.09%报0.500港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426901449","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426901449?lang=zh_cn&edition=full","pubTime":"2024-04-09 09:41","pubTimestamp":1712626870,"startTime":"0","endTime":"0","summary":"2024年04月09日早盘09时41分,堃博医疗-B股票出现波动,股价大幅跳水9.09%。截至发稿,该股报0.500港元/股,成交量6.15万股,换手率0.01%,振幅3.64%。资金方面,该股资金流入0港元,流出4160港元。堃博医疗-B股票所在的医疗设备及用品行业中,整体涨幅为0.02%。堃博医疗-B公司简介:堃博医疗控股有限公司是一家提供创新型肺部疾病解决方案的中国投资控股公司。肺癌治疗解决方案产品包括针对肺癌的InterVapor和H-Marker等。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240409094110791f4645&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240409094110791f4645&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424872760","title":"堃博医疗-B股价重挫10.53% 市值跌2831.2万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2424872760","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424872760?lang=zh_cn&edition=full","pubTime":"2024-04-02 10:15","pubTimestamp":1712024140,"startTime":"0","endTime":"0","summary":"2024年04月02日早盘10时15分,堃博医疗-B股票出现异动,股价急速下挫10.53%。截至发稿,该股报0.510港元/股,成交量2000股,换手率0.00%,振幅0.00%。资金方面,该股资金流入0港元,流出1020港元。堃博医疗-B股票所在的医疗设备及用品行业中,整体跌幅为0.10%。肺癌治疗解决方案产品包括针对肺癌的InterVapor和H-Marker等。消息层面,截至10时15分,《堃博医疗-B年报点评:内生收入快速增长,期待持续改善》资讯为影响堃博医疗-B的重要信息。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240402101541791e5932&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240402101541791e5932&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424080052","title":"(坤)博医疗-B(02216)股价显著下跌10.526%,现价港币$0.51","url":"https://stock-news.laohu8.com/highlight/detail?id=2424080052","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2424080052?lang=zh_cn&edition=full","pubTime":"2024-04-02 10:15","pubTimestamp":1712024100,"startTime":"0","endTime":"0","summary":"[下跌股](坤)博医疗-B(02216) 股价在上午10:15比前收市价显著下跌10.526%,现股价为港币$0.51。至目前为止,今日最高价为$0.51,而最低价为$0.51。总成交量为2000股,总成交金额为港币$1020。","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180725131622959_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180725131622959_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2404021701/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2424615657","title":"堃博医疗-B(02216)年报点评:内生收入快速增长,期待持续改善","url":"https://stock-news.laohu8.com/highlight/detail?id=2424615657","media":"华泰证券","top":-1,"share":"https://www.laohu8.com/m/news/2424615657?lang=zh_cn&edition=full","pubTime":"2024-04-01 16:19","pubTimestamp":1711959571,"startTime":"0","endTime":"0","summary":"23年公司内生收入快速增长,期待24年持续改善公司23年实现收入/净亏损1026/2809万美元,低于我们预期,我们推测主因国内行业外部因素短期影响院内设备招标及新品入院节奏叠加公司专利对外授权终止后相关收入冲回。若剔除特许权收入冲回影响,公司24年实际产品销售及对外服务收入1241万美元,内生收入保持快速增长。我们预计公司24-26年实现收入1303/1703/2165万美元,并看好公司25年净利润转正。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404011630298ae34d09&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404011630298ae34d09&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422221115","title":"堃博医疗-B(02216)发2023年度业绩,股东应占亏损2809.1万美元,同比扩大0.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422221115","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2422221115?lang=zh_cn&edition=full","pubTime":"2024-03-28 22:55","pubTimestamp":1711637704,"startTime":"0","endTime":"0","summary":"智通财经APP讯,堃博医疗-B(02216)发布截至2023年12月31日止年度业绩公告,公司收入1025.5万美元,同比增长8.9%;毛利722.7万美元,同比下降1.2%;母公司拥有人应占年内亏损2809.1万美元,同比扩大0.2%;基本每股亏损0.06美元。报告期内,集团的收入主要为销售医疗器械及耗材产生。截至2023年12月31日止年度,集团的收入较去年上涨8.9%,其中销售医疗器械及耗材收入1240万美元,收入较去年上涨31.8%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1095530.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2422113689","title":"堃博医疗(02216.HK)公布2023年年度业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2422113689","media":"美通社","top":-1,"share":"https://www.laohu8.com/m/news/2422113689?lang=zh_cn&edition=full","pubTime":"2024-03-28 22:27","pubTimestamp":1711636020,"startTime":"0","endTime":"0","summary":"肺病治疗产品研发持续领先,产品销售稳健推进 杭州2024年3月28日 /美通社/ -- 2024年3月28日,中国肺部疾病精准介入诊疗领军者堃博医疗公布其截至2023年12月31日的年度业绩。报告期内,公司实现产品销售收入1241万美元,同比增长32%。治疗产品研发及临床进展仍居世界前列 堃博医疗针对肺部疾病介入治疗的产品研发与临床试验进展持续领先全球。国产化与术式普及释放公司新动能 2023年,公司的国产化战略成果初步显现。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4373506_ZH73506_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2420757356","title":"堃博医疗-B盘中异动 急速下挫6.35%报0.590港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2420757356","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420757356?lang=zh_cn&edition=full","pubTime":"2024-03-20 11:51","pubTimestamp":1710906678,"startTime":"0","endTime":"0","summary":"2024年03月20日临近午盘11时51分,堃博医疗-B股票出现波动,股价急速跳水6.35%。截至发稿,该股报0.590港元/股,成交量6.05万股,换手率0.01%,振幅3.17%。堃博医疗-B股票所在的医疗设备及用品行业中,整体涨幅为0.03%。肺癌治疗解决方案产品包括针对肺癌的InterVapor和H-Marker等。该信息摘要如下:堃博医疗-B即将审批全年业绩。3月18日,堃博医疗-B宣布,将于2024年3月28日召开董事会会议。会议的主要议程是审批公司及其附属公司截至2023年12月31日的年度业绩。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403201151207a4dd6c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403201151207a4dd6c9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420472214","title":"堃博医疗-B(02216.HK)即将审批2023年全年业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2420472214","media":"和讯网","top":-1,"share":"https://www.laohu8.com/m/news/2420472214?lang=zh_cn&edition=full","pubTime":"2024-03-18 21:41","pubTimestamp":1710769296,"startTime":"0","endTime":"0","summary":"快讯正文堃博医疗-B即将审批全年业绩。3月18日,堃博医疗-B宣布,将于2024年3月28日召开董事会会议。会议的主要议程是审批公司及其附属公司截至2023年12月31日的年度业绩。和讯自选股写手风险提示:以上内容仅作为作者或者嘉宾的观点,不代表和讯的任何立场,不构成与和讯相关的任何投资建议。在作出任何投资决定前,投资者应根据自身情况考虑投资产品相关的风险因素,并于需要时咨询专业投资顾问意见。和讯竭力但不能证实上述内容的真实性、准确性和原创性,对此和讯不做任何保证和承诺。下载和讯APP查看快讯,体验更佳>>","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031821555487936828&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031821555487936828&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420427488","title":"堃博医疗-B(02216.HK)将于3月28日举行董事会会议以审批全年业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2420427488","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2420427488?lang=zh_cn&edition=full","pubTime":"2024-03-18 19:36","pubTimestamp":1710761771,"startTime":"0","endTime":"0","summary":"格隆汇3月18日丨堃博医疗-B(02216.HK)公告,公司将于2024年3月28日举行董事会会议,以通过公司及其附属公司截至2023年12月31日止年度的全年业绩。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403181936218b42fac2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403181936218b42fac2&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420414793","title":"堃博医疗-B盘中异动 股价大跌5.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2420414793","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420414793?lang=zh_cn&edition=full","pubTime":"2024-03-18 14:27","pubTimestamp":1710743279,"startTime":"0","endTime":"0","summary":"2024年03月18日下午盘14时27分,堃博医疗-B股票出现波动,股价急速下跌5.97%。堃博医疗-B股票所在的医疗设备及用品行业中,整体涨幅为0.06%。其相关个股中,康基医疗、佳兆业健康、永胜医疗涨幅较大,振幅较大的相关个股有百心安-B、紫元元、巨星医疗控股,振幅分别为14.54%、11.88%、11.76%。堃博医疗-B公司简介:堃博医疗控股有限公司是一家提供创新型肺部疾病解决方案的中国投资控股公司。肺癌治疗解决方案产品包括针对肺癌的InterVapor和H-Marker等。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403181428007a4d537c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403181428007a4d537c&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.broncus.com","stockEarnings":[{"period":"1week","weight":-0.0556},{"period":"1month","weight":-0.1053},{"period":"3month","weight":-0.25},{"period":"6month","weight":-0.49},{"period":"1year","weight":-0.7182},{"period":"ytd","weight":-0.3544}],"compareEarnings":[{"period":"1week","weight":0.0548},{"period":"1month","weight":0.0401},{"period":"3month","weight":0.0835},{"period":"6month","weight":-0.0066},{"period":"1year","weight":-0.1252},{"period":"ytd","weight":0.0139}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"堃博医疗控股有限公司是一家提供创新型肺部疾病解决方案的中国投资控股公司。该公司的业务包括提供诊断解决方案、肺癌治疗解决方案、慢性阻塞性肺病解决方案和导航平台。诊断解决方案的产品包括FleXNeedle,ATV鞘管和ATV球囊等。肺癌治疗解决方案产品包括针对肺癌的InterVapor和H-Marker等。慢性阻塞性肺病解决方案产品包括针对慢性阻塞性肺病的InterVapor和靶向肺去神经消融系统。导航平台产品包括Lungpoint,Lungpro,和新一代导航系统等。","exchange":"SEHK","name":"堃博医疗-B","nameEN":"BRONCUS-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"堃博医疗-B(02216)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供堃博医疗-B(02216)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"堃博医疗-B,02216,堃博医疗-B股票,堃博医疗-B股票老虎,堃博医疗-B股票老虎国际,堃博医疗-B行情,堃博医疗-B股票行情,堃博医疗-B股价,堃博医疗-B股市,堃博医疗-B股票价格,堃博医疗-B股票交易,堃博医疗-B股票购买,堃博医疗-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"堃博医疗-B(02216)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供堃博医疗-B(02216)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}